These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 39201590)

  • 1. Synthesis and Anti-Cancer Activity of the Novel Selective Glucocorticoid Receptor Agonists of the Phenylethanolamine Series.
    Zhidkova EM; Tilova LR; Fetisov TI; Kirsanov KI; Kulikov EP; Enikeev AD; Budunova IV; Badun GA; Chernysheva MG; Shirinian VZ; Yakubovskaya MG; Lesovaya EA
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effect of non-steroid glucocorticoid receptor ligand CpdA on leukemia cell lines CEM and K562.
    Lesovaya EA; Yemelyanov AY; Kirsanov KI; Yakubovskaya MG; Budunova IV
    Biochemistry (Mosc); 2011 Nov; 76(11):1242-52. PubMed ID: 22117551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor Transrepression.
    Zheng Y; Ishiguro H; Ide H; Inoue S; Kashiwagi E; Kawahara T; Jalalizadeh M; Reis LO; Miyamoto H
    Mol Endocrinol; 2015 Oct; 29(10):1486-97. PubMed ID: 26322830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignancies.
    Lesovaya E; Yemelyanov A; Kirsanov K; Popa A; Belitsky G; Yakubovskaya M; Gordon LI; Rosen ST; Budunova I
    Cell Cycle; 2013 Jan; 12(1):133-44. PubMed ID: 23255118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Compound A--a selective activator of the glucocorticoid receptor with anti-inflammatory and anti-cancer activity.
    Lesovaya E; Yemelyanov A; Swart AC; Swart P; Haegeman G; Budunova I
    Oncotarget; 2015 Oct; 6(31):30730-44. PubMed ID: 26436695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential targeting of androgen and glucocorticoid receptors induces ER stress and apoptosis in prostate cancer cells: a novel therapeutic modality.
    Yemelyanov A; Bhalla P; Yang X; Ugolkov A; Iwadate K; Karseladze A; Budunova I
    Cell Cycle; 2012 Jan; 11(2):395-406. PubMed ID: 22223138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of combining glucocorticoids with Compound A on glucocorticoid receptor responsiveness in lymphoid malignancies.
    Clarisse D; Van Wesemael K; Tavernier J; Offner F; Beck IM; De Bosscher K
    PLoS One; 2018; 13(5):e0197000. PubMed ID: 29738549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective non-steroidal glucocorticoid receptor agonists attenuate inflammation but do not impair intestinal epithelial cell restitution in vitro.
    Reuter KC; Loitsch SM; Dignass AU; Steinhilber D; Stein J
    PLoS One; 2012; 7(1):e29756. PubMed ID: 22295067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic and adverse effects of a non-steroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis.
    Wüst S; Tischner D; John M; Tuckermann JP; Menzfeld C; Hanisch UK; van den Brandt J; Lühder F; Reichardt HM
    PLoS One; 2009 Dec; 4(12):e8202. PubMed ID: 19997594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective glucocorticoid receptor agonists for the treatment of inflammatory bowel disease: studies in mice with acute trinitrobenzene sulfonic acid colitis.
    Reuter KC; Grunwitz CR; Kaminski BM; Steinhilber D; Radeke HH; Stein J
    J Pharmacol Exp Ther; 2012 Apr; 341(1):68-80. PubMed ID: 22235147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abrogation of glucocorticoid receptor dimerization correlates with dissociated glucocorticoid behavior of compound a.
    Robertson S; Allie-Reid F; Vanden Berghe W; Visser K; Binder A; Africander D; Vismer M; De Bosscher K; Hapgood J; Haegeman G; Louw A
    J Biol Chem; 2010 Mar; 285(11):8061-75. PubMed ID: 20037160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Activator of the Glucocorticoid Receptor Compound A Dissociates Therapeutic and Atrophogenic Effects of Glucocorticoid Receptor Signaling in Skin.
    Klopot A; Baida G; Bhalla P; Haegeman G; Budunova I
    J Cancer Prev; 2015 Dec; 20(4):250-9. PubMed ID: 26734587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
    Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I
    Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GR-independent down-modulation on GM-CSF bone marrow-derived dendritic cells by the selective glucocorticoid receptor modulator Compound A.
    Barcala Tabarrozzi AE; Andreone L; Deckers J; Castro CN; Gimeno ML; Ariolfo L; Berguer PM; Antunica-Noguerol M; Liberman AC; Vettorazzi S; Tuckermann JP; De Bosscher K; Perone MJ
    Sci Rep; 2016 Nov; 6():36646. PubMed ID: 27857212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The autophagy receptor SQSTM1/p62 mediates anti-inflammatory actions of the selective NR3C1/glucocorticoid receptor modulator compound A (CpdA) in macrophages.
    Mylka V; Deckers J; Ratman D; De Cauwer L; Thommis J; De Rycke R; Impens F; Libert C; Tavernier J; Vanden Berghe W; Gevaert K; De Bosscher K
    Autophagy; 2018; 14(12):2049-2064. PubMed ID: 30215534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay of the inflammatory and stress systems in a hepatic cell line: interactions between glucocorticoid receptor agonists and interleukin-6.
    Visser K; Smith C; Louw A
    Endocrinology; 2010 Nov; 151(11):5279-93. PubMed ID: 20881254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compound A, a selective glucocorticoid receptor agonist, inhibits immunoinflammatory diabetes, induced by multiple low doses of streptozotocin in mice.
    Saksida T; Vujicic M; Nikolic I; Stojanovic I; Haegeman G; Stosic-Grujicic S
    Br J Pharmacol; 2014 Dec; 171(24):5898-909. PubMed ID: 25158597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the selective glucocorticoid receptor modulator compound A on bone metabolism and inflammation in male mice with collagen-induced arthritis.
    Rauner M; Thiele S; Sinningen K; Winzer M; Salbach-Hirsch J; Gloe I; Peschke K; Haegeman G; Tuckermann JP; Hofbauer LC
    Endocrinology; 2013 Oct; 154(10):3719-28. PubMed ID: 23885015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective modulation of the glucocorticoid receptor can distinguish between transrepression of NF-κB and AP-1.
    De Bosscher K; Beck IM; Dejager L; Bougarne N; Gaigneaux A; Chateauvieux S; Ratman D; Bracke M; Tavernier J; Vanden Berghe W; Libert C; Diederich M; Haegeman G
    Cell Mol Life Sci; 2014 Jan; 71(1):143-63. PubMed ID: 23784308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The possible separation of 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation and hyperplasia by compound A.
    Kowalczyk P; Kowalczyk MC; Junco JJ; Tolstykh O; Kinjo T; Truong H; Walaszek Z; Hanausek M; Slaga TJ
    Mol Carcinog; 2013 Jun; 52(6):488-96. PubMed ID: 22351517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.